JP2022553307A5 - - Google Patents
Info
- Publication number
- JP2022553307A5 JP2022553307A5 JP2022523408A JP2022523408A JP2022553307A5 JP 2022553307 A5 JP2022553307 A5 JP 2022553307A5 JP 2022523408 A JP2022523408 A JP 2022523408A JP 2022523408 A JP2022523408 A JP 2022523408A JP 2022553307 A5 JP2022553307 A5 JP 2022553307A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924340P | 2019-10-22 | 2019-10-22 | |
| US62/924,340 | 2019-10-22 | ||
| PCT/US2020/056860 WO2021081201A1 (en) | 2019-10-22 | 2020-10-22 | Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegeneative diseases or disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553307A JP2022553307A (ja) | 2022-12-22 |
| JPWO2021081201A5 JPWO2021081201A5 (https=) | 2023-10-30 |
| JP2022553307A5 true JP2022553307A5 (https=) | 2023-10-30 |
Family
ID=75620215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523408A Pending JP2022553307A (ja) | 2019-10-22 | 2020-10-22 | プログラニュリン関連神経変性疾患または障害の治療のためのアデノ随伴ウイルス（ａａｖ）システム |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210147872A1 (https=) |
| EP (1) | EP4048799A4 (https=) |
| JP (1) | JP2022553307A (https=) |
| KR (1) | KR20230019402A (https=) |
| CN (1) | CN115715327A (https=) |
| AU (1) | AU2020371662A1 (https=) |
| CA (1) | CA3158516A1 (https=) |
| IL (1) | IL292382A (https=) |
| MX (1) | MX2022004812A (https=) |
| WO (1) | WO2021081201A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021533126A (ja) * | 2018-07-31 | 2021-12-02 | コーネル・ユニバーシティーCornell University | 臓器機能を制御するための遺伝子治療方法 |
| KR20230128001A (ko) * | 2020-12-01 | 2023-09-01 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 엔젤만 증후군의 치료를 위한 조성물 및 이의 용도 |
| US20240033332A1 (en) * | 2020-12-17 | 2024-02-01 | Kyoto University | Agent for activating a neuron |
| WO2024035649A1 (en) * | 2022-08-08 | 2024-02-15 | Shape Therapeutics Inc. | Compositions for progranulin expression and methods of use thereof |
| KR20250131772A (ko) * | 2022-11-13 | 2025-09-03 | 알렉시온 파마 인터내셔널 오퍼레이션즈 리미티드 | 전두측두엽 치매에 대한 유전자 요법 |
| WO2025251041A1 (en) * | 2024-05-31 | 2025-12-04 | Bluerock Therapeutics Lp | METHODS AND COMPOSITIONS FOR TREATING PROGRANULIN DEFICIENCIES USING iPSC-DERIVED CELLS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009089635A1 (en) * | 2008-01-16 | 2009-07-23 | Neurodyn, Inc. | Treating neurodegenerative diseases with progranulin (pgrn) |
| JP5879256B2 (ja) * | 2009-05-02 | 2016-03-08 | ジェンザイム・コーポレーション | 神経変性障害のための遺伝子治療 |
| AU2013243948A1 (en) * | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins associated with human disease |
| WO2016125330A1 (ja) * | 2015-02-02 | 2016-08-11 | 原 英彰 | 網膜再生促進薬 |
| WO2017151884A1 (en) * | 2016-03-02 | 2017-09-08 | The Children's Hospital Of Philadelphia | Therapy for frontotemporal dementia |
| WO2018136680A1 (en) * | 2017-01-19 | 2018-07-26 | New York University | Progranulin and progranulin derivatives in treating impaired fracture healing |
| EP3692075A4 (en) * | 2017-10-03 | 2022-02-09 | Prevail Therapeutics, Inc. | GENE THERAPIES FOR LYSOSOMAL DISEASES |
| KR102709597B1 (ko) * | 2017-10-03 | 2024-09-26 | 프리베일 테라퓨틱스, 인크. | 리소좀 장애를 위한 유전자 요법 |
| US20220111005A1 (en) * | 2019-02-01 | 2022-04-14 | Avrobio, Inc. | Compositions and methods for treating neurocognitive disorders |
| BR112021015817A2 (pt) * | 2019-02-22 | 2021-10-13 | The Trustees Of The University Of Pennsylvania | Vírus adeno-associado recombinante para tratamento de neurodegeneração com início na idade adulta associado a grn |
-
2020
- 2020-10-22 IL IL292382A patent/IL292382A/en unknown
- 2020-10-22 EP EP20880235.5A patent/EP4048799A4/en active Pending
- 2020-10-22 MX MX2022004812A patent/MX2022004812A/es unknown
- 2020-10-22 CA CA3158516A patent/CA3158516A1/en active Pending
- 2020-10-22 WO PCT/US2020/056860 patent/WO2021081201A1/en not_active Ceased
- 2020-10-22 US US17/077,680 patent/US20210147872A1/en not_active Abandoned
- 2020-10-22 CN CN202080089386.1A patent/CN115715327A/zh active Pending
- 2020-10-22 AU AU2020371662A patent/AU2020371662A1/en not_active Abandoned
- 2020-10-22 KR KR1020227017064A patent/KR20230019402A/ko not_active Ceased
- 2020-10-22 JP JP2022523408A patent/JP2022553307A/ja active Pending
-
2023
- 2023-09-26 US US18/372,868 patent/US20240318199A1/en active Pending